Palleiko Benjamin L

CIK 00013662443 companiesFRAMINGHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001366244

Recent Transactions

50 trades

Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-06-11−479,989→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−75,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−40,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−71,700→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−47,354→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−33,800→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-06-11−92,560→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-06-11−125,001→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−25,800→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−29,611→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−33,750→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−37,500→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−52,600→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-06-11−304,688→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−20,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−113,920→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-06-11−255,750→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−85,000→ 0 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-22$26.78/sh−10,926→ 479,989 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-21+23,250→ 490,915 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-05-21−23,250→ 255,750 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-18$26.76/sh−1,129→ 467,665 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-05-17−2,419→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-17+2,419→ 468,794 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-12$26.71/sh−3,322→ 466,375 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-05-11+7,120→ 469,697 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-05-11−7,120→ 92,560 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-04-17$20.22/sh−9,550→ 462,577 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-04-16+20,312→ 472,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-04-16−20,312→ 304,688 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-03-09$16.08/sh−6,693→ 451,815 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-03-06−15,625→ 125,001 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-03-06+15,625→ 458,508 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-23$15.57/sh−10,034→ 442,883 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-21+23,250→ 452,917 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-21−23,250→ 279,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-18$15.00/sh−1,038→ 429,667 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-17−2,419→ 2,419 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-17+2,419→ 430,705 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-12$15.70/sh−3,354→ 428,286 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-11−7,120→ 99,680 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-11+7,120→ 431,640 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-01-16+325,000→ 325,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-12-08$16.51/sh−7,294→ 424,520 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-12-06+15,625→ 431,814 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-12-06−15,625→ 140,626 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−10,940→ 416,189 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+23,250→ 427,129 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−23,250→ 302,250 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-18$14.48/sh−4,466→ 403,879 total

Companies

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov